(-0.08%) 5 464.78 points
(-0.06%) 39 088 points
(0.16%) 17 746 points
(-0.69%) $80.27
(-4.32%) $2.64
(-0.85%) $2 311.00
(0.01%) $28.87
(2.30%) $1 009.10
(0.31%) $0.936
(0.74%) $10.68
(0.48%) $0.792
(-0.14%) $87.37
Live Chart Being Loaded With Signals
Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods...
Stats | |
---|---|
Today's Volume | 1 734 |
Average Volume | 0 |
Market Cap | 32.46M |
EPS | $-0.0603 ( Q2 | 2024-04-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-26 | Carle Vanessa | Buy | 12 500 | Stock Options |
2023-10-26 | Docherty John Martin | Buy | 30 000 | Stock Options |
2023-10-26 | Bunka Christopher | Buy | 30 000 | Stock Options |
2023-07-25 | Baxter Nicholas W | Buy | 5 000 | Stock Options |
2023-07-25 | Mckechnie William Edward | Buy | 5 000 | Stock Options |
INSIDER POWER |
---|
95.95 |
Last 99 transactions |
Buy: 5 639 011 | Sell: 3 601 735 |
Lexaria Bioscience Corp. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lexaria Bioscience Corp. Financials
Annual | 2023 |
Revenue: | $226 208 |
Gross Profit: | $194 708 (86.07 %) |
EPS: | $-1.010 |
FY | 2023 |
Revenue: | $226 208 |
Gross Profit: | $194 708 (86.07 %) |
EPS: | $-1.010 |
FY | 2022 |
Revenue: | $255 397 |
Gross Profit: | $183 556 (71.87 %) |
EPS: | $-1.240 |
FY | 2021 |
Revenue: | $722 738 |
Gross Profit: | $547 392 (75.74 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company\'s DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators